Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Clinical trial NCT04749355 · UNKNOWN

Trial details

NCT number: NCT04749355
Sponsor: BioSight Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

AML, Adult MDS Relapse/Recurrence Refractory Acute Myeloid Leukemia

Start date: 2021-11-14
Primary completion: 2023-12-14
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.